Filters: author is Tuk [Clear All Filters]
- 2002
Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol,
J Pharmacokinet Pharmacodyn, vol. 29, no. 3, pp. 235-50.
- 2000
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep,
Clin Pharmacol Ther, vol. 68, no. 2, pp. 175-88.
- 1999
Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam,
J Pharmacol Exp Ther, vol. 289, no. 2, pp. 1067-74.
- 1998
Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam,
J Pharmacol Exp Ther, vol. 284, no. 1, pp. 202-7.
- 1997
Pharmacodynamics of temazepam in primary insomnia: assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep,
Clin Pharmacol Ther, vol. 62, no. 4, pp. 444-52.
The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates,
J Pharmacokinet Biopharm, vol. 25, no. 1, pp. 39-62.
- 1993
A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity,
Br J Clin Pharmacol, vol. 36, no. 2, pp. 109-15.
- 1992
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers,
Clin Pharmacol Ther, vol. 51, no. 6, pp. 715-28.
